The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.
It’s approved by the Food and Drug Administration (FDA ... the medication and those who were less likely to develop cognitive ...
Alzheimer’s has no cure and can’t be reversed, but the FDA-approved drug can slow cognitive decline. Eli Lilly reported that ...
Denise Galloni is relieved that the U.S. Food and Drug Administration (FDA) has granted traditional approval to the drug sold ...
The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to ...